Completed
Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications
NCT04847895
- Conditions
- Cardiovascular Diseases, Choroid Diseases, Choroidal Neovascularization, +15 more
- Locations
-
- Novartis Investigative Site Ettlingen, Baden-Wurttemberg, Germany
- Novartis Investigative Site Ahaus, Germany
- Novartis Investigative Site Andernach, Germany
- Novartis Investigative Site Augsburg, Germany